136 related articles for article (PubMed ID: 35716936)
1. Gaps of evidence in pulmonary arterial hypertension.
Vizza CD; Ghio S; Badagliacca R; Manzi G; Scelsi L; Argiento P; D'Alto M
Int J Cardiol; 2022 Oct; 364():119-123. PubMed ID: 35716936
[No Abstract] [Full Text] [Related]
2. Prognostic Stratification and Treatment for Pulmonary Arterial Hypertension. Gaps and Promising Remedies.
Del Pozo R; Cruz-Utrilla A; Escribano-Subias P
Arch Bronconeumol; 2023 Oct; 59(10):617-618. PubMed ID: 37147267
[No Abstract] [Full Text] [Related]
3. Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
Humbert M; Lau EMT
Am J Respir Crit Care Med; 2021 Mar; 203(6):675-677. PubMed ID: 33357026
[No Abstract] [Full Text] [Related]
4. The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
Haarman MG; Douwes JM; Ploegstra MJ; Roofthooft MTR; Vissia-Kazemier TR; Hillege HL; Berger RMF
Am J Respir Crit Care Med; 2019 Nov; 200(10):1312-1315. PubMed ID: 31298925
[No Abstract] [Full Text] [Related]
5. The Oracle of the Auricle?: Optimizing Serial Risk Stratification of Patients With Pulmonary Arterial Hypertension.
Shelburne NJ; Frantz RP
Chest; 2022 Sep; 162(3):509-510. PubMed ID: 36088091
[No Abstract] [Full Text] [Related]
6. Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
Singh N; Ventetuolo CE
Am J Respir Crit Care Med; 2022 May; 205(9):988-990. PubMed ID: 35143371
[No Abstract] [Full Text] [Related]
7. The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.
Sharma D; Shah RJ; Sreenivasan J; Kafle P; Gupta R; Levine A; Lanier GM; Aronow WS
Expert Rev Cardiovasc Ther; 2022 Jul; 20(7):543-547. PubMed ID: 35726644
[TBL] [Abstract][Full Text] [Related]
8. The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
Ford HJ; LeVarge B
Chest; 2021 Jan; 159(1):14-16. PubMed ID: 33422195
[No Abstract] [Full Text] [Related]
9. Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
Pausch C; Pittrow D; Hoeper MM; Huscher D
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37802633
[TBL] [Abstract][Full Text] [Related]
10. Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
Fauvel C; White RJ; Vanderpool RR; Badagliacca R; Tobore T; Rahman M; Vizza CD; Lin S; Everett AD; Visovatti SH; Benza RL
Chest; 2024 Feb; 165(2):431-436. PubMed ID: 37709252
[No Abstract] [Full Text] [Related]
11. Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation.
Olsson KM; Richter MJ; Kamp JC; Gall H; Ghofrani HA; Fuge J; Ewert R; Hoeper MM
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35144993
[No Abstract] [Full Text] [Related]
12. [A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults].
Shmalts AA; Gorbachevsky SV
Ter Arkh; 2019 Dec; 91(12):105-114. PubMed ID: 32598597
[TBL] [Abstract][Full Text] [Related]
13. Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.
Richter MJ; Tello K
Am J Respir Crit Care Med; 2020 Feb; 201(4):403-405. PubMed ID: 31726011
[No Abstract] [Full Text] [Related]
14. Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
Vraka A; Yerly P; Aubert JD
Respiration; 2022; 101(6):565-576. PubMed ID: 35045412
[TBL] [Abstract][Full Text] [Related]
15. Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.
Corris PA; Seeger W
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L992-L994. PubMed ID: 32233785
[No Abstract] [Full Text] [Related]
16. Where's the Easy Button? The Many Barriers to Care for Patients With Pulmonary Arterial Hypertension.
Cantres-Fonseca O; Kennedy JLW
J Am Heart Assoc; 2022 Nov; 11(22):e027967. PubMed ID: 36370008
[No Abstract] [Full Text] [Related]
17. Raising the bar: triple therapy for pulmonary arterial hypertension associated with congenital heart disease.
D'Alto M; Bassareo PP
Heart; 2024 Feb; 110(5):309-310. PubMed ID: 37903554
[No Abstract] [Full Text] [Related]
18. Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial.
Kopeć G
Cardiovasc Res; 2023 Dec; 119(16):e155-e157. PubMed ID: 37584249
[No Abstract] [Full Text] [Related]
19. Pulmonary arterial hypertension registries: past, present and into the future.
Weatherald J; Reis A; Sitbon O; Humbert M
Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31852747
[TBL] [Abstract][Full Text] [Related]
20. Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.
Shi Y; Dong X; Hu X; Weng L; Liu Y; Lai J; Tian Z; Zhao J; Li M; Peng J; Wang Q; Zeng X
BMC Pulm Med; 2022 Jul; 22(1):264. PubMed ID: 35790938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
